432 filings
Page 4 of 22
8-K
207nn omucj
26 Oct 21
Other Events
8:00am
8-K
gr301p
16 Aug 21
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
4:01pm
EFFECT
jyhi1t0jljpk
7 Jun 21
Notice of effectiveness
12:15am
POS AM
6bqvu djmua
18 May 21
Prospectus update (post-effective amendment)
12:00am
S-8
o6yi8vg1r zkwo
18 May 21
Registration of securities for employees
12:00am
8-K
04xjm xmk83k6a4
17 May 21
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
5:27pm
8-K
el6v9xb89m
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
vwfz5ukd lnnzki
25 Mar 21
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
9:17am
425
wkuj8f
25 Mar 21
Business combination disclosure
9:15am
8-K
a9sf2
16 Mar 21
Other Events
7:02am
425
10yr0txi2
16 Mar 21
Business combination disclosure
7:00am
DEFR14A
obza8
26 Feb 21
Revised proxy
4:46pm
8-K
00y2w63bpxyuw irn
26 Feb 21
Entry into a Material Definitive Agreement
4:42pm
425
7uvluv
26 Feb 21
Business combination disclosure
4:40pm
8-K
k4ic8k
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
424B5
xicb o1ad2ek
16 Feb 21
Prospectus supplement for primary offering
12:00am